SBIR/STTR Research Award
Hemostatic Agent Development
Award amount
$1,000,000Program and phase
SBIR · Phase IIAward year
2020Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- HYBRID PLASTICS
- Proposal award date
- 2020-09-24
- Contract end date
- 2023-01-23
- UEI
- MPMJGN56FGB5
- Solicitation number
- 10.1
- Topic code
- N101-085
Research abstract
The proposed effort aims to increase the TRL of the hemostatic agent through completion of relevant animal and toxicological research and development. These advancements will be verified through process improvements to meet good manufacturing practices.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- POSS Nanochemical Technology for Radiation Hardened/Tolerant Systems
- Solid Polymer Electrolytes with High Lithium Ion Conductivity and Transport Number for Hybrid Electric Power-train Systems
- Anion Exchange Polymer Membranes Based on Polyoctahedral Silsesquioxanes for Alkaline Fuel Cells
- POSS TCP Resin System for Carbon Fiber Reinforced Composite Shipboard Applications
- Space and Operational Environmental Protection for Thin Multijunction Solar Cells
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Multi-functional Synthetic Co-polypeptides as Hemostatic Agents
- Hemostatic Agent Development
- Hemostatic Agent Development
Research funding history
21 SBIR/STTR records share this UEI (2001–2020). Reported award amounts total $6,722,188. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, National Science Foundation, Department of Health and Human Services, Department of Energy